ACP5 and melanoma: Indeed, quantification of TRAP+ cells resembling bone-resorbing osteoclasts showed that melanoma cells exposed to HFD-serum significantly enhanced osteoclast differentiation (Figures 2C-2E, Figure S3A-S3C).